PRCT
PROCEPT BioRobotics Corporation
Price Chart
Latest Quote
$19.22
+0.02 (+0.10%)
Current Price
| Previous Close | $19.20 |
| Open | $18.81 |
| Day High | $19.37 |
| Day Low | $18.12 |
| Volume | 2,054,818 |
Stock Information
| Shares Outstanding | 56.92M |
| Total Debt | $78.00M |
| Cash Equivalents | $245.64M |
| Revenue | $322.02M |
| Net Income | $-102.47M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.09B |
| EPS (TTM) | $-1.83 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $926.34M |
| Sales | $322.02M |
| Income | $-102.47M |
| Book/sh | $6.11 |
| Cash/sh | $4.32 |
| Employees | 888 |
Financial Ratios
| Quick Ratio | 5.38 |
| Current Ratio | 6.73 |
| Debt/Eq | 22.43 |
Returns & Margins
| ROA | -13.54% |
| ROE | -27.82% |
| Gross Margin | 63.97% |
| Operating Margin | -39.22% |
| Profit Margin | -31.82% |
Ownership
| Insider Ownership | 3.17% |
| Institutional Ownership | 101.93% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -21.57 |
| P/S | 3.40 |
| P/B | 3.15 |
Analyst Data
| Recommendation | buy |
| Target Price | $29.30 |
Technical Indicators
| SMA20 | $20.94 |
| SMA50 | $24.29 |
| SMA200 | $28.37 |
| RSI | 30.58 |
| ATR | 1.4868 |
| Shares Float | 55.51M |
| Short Float | 13.84% |
| Short Ratio | 4.51 |
| Volatility | 0.87 |
| Rel Volume | 1.23 |
Performance History
| Week | -7.99% |
| Month | -13.03% |
| Quarter | -21.62% |
| 6 Months | -38.73% |
| YTD | -37.52% |
| Year | -66.30% |
| 3 Years | -49.51% |
| 10 Years | -54.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $19.22 | 2,054,818 |
| 2026-07-16 | $19.20 | 1,586,900 |
| 2026-07-15 | $19.15 | 2,391,900 |
| 2026-07-14 | $19.31 | 1,890,200 |
| 2026-07-13 | $21.22 | 1,084,900 |
| 2026-07-10 | $20.89 | 1,229,900 |
| 2026-07-09 | $19.75 | 1,540,100 |
| 2026-07-08 | $19.80 | 2,024,200 |
| 2026-07-07 | $21.03 | 1,449,000 |
| 2026-07-06 | $21.21 | 1,407,700 |
| 2026-07-02 | $21.03 | 1,730,600 |
| 2026-07-01 | $23.47 | 1,349,500 |
| 2026-06-30 | $22.58 | 1,302,600 |
| 2026-06-29 | $22.58 | 1,127,100 |
| 2026-06-26 | $22.56 | 2,650,100 |
| 2026-06-25 | $21.49 | 1,738,600 |
| 2026-06-24 | $20.85 | 1,831,400 |
| 2026-06-23 | $20.60 | 2,025,900 |
| 2026-06-22 | $21.06 | 1,232,100 |
| 2026-06-18 | $21.72 | 1,781,500 |
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
đ° Latest News
Evercore Initiates PROCEPT BioRobotics (PRCT) At âOutperform,â Cites Aquablation Growth Potential
Insider Monkey âĸ 2026-06-30T02:04:18Z
Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now
Insider Monkey âĸ 2026-06-25T06:02:11Z
BlackBerry, Take-Two initiations among today's top calls on Wall Street
The Fly âĸ 2026-06-24T13:31:45Z
Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-19T15:33:20Z
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-11T13:38:31Z
Here Are Thursdayâs Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
24/7 Wall St. âĸ 2026-06-11T12:04:30Z
PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's Changed
Simply Wall St. âĸ 2026-06-01T01:04:04Z
Hereâs What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)
Insider Monkey âĸ 2026-05-26T12:08:53Z
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
Motley Fool âĸ 2026-05-23T20:37:22Z
5 Robotics Stocks to Watch as Physical AI Builds Momentum
MarketBeat âĸ 2026-05-18T15:20:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $111,828,000 | $87,399,000 | $65,142,000 | $37,929,000 |
| Cost Of Revenue | $111,828,000 | $87,399,000 | $65,142,000 | $37,929,000 |
| Total Revenue | $308,054,000 | $224,498,000 | $136,191,000 | $75,014,000 |
| Operating Revenue | $308,054,000 | $224,498,000 | $136,191,000 | $75,014,000 |
| Expenses | ||||
| Interest Expense | $3,586,000 | $4,184,000 | $3,995,000 | $5,183,000 |
| Total Expenses | $411,913,000 | $321,112,000 | $245,361,000 | $155,738,000 |
| Other Income Expense | $-156,000 | $-1,142,000 | $-203,000 | $-3,744,000 |
| Other Non Operating Income Expenses | $-156,000 | $-1,028,000 | $-96,000 | $-203,000 |
| Net Non Operating Interest Income Expense | $8,633,000 | $6,711,000 | $3,556,000 | $-2,686,000 |
| Interest Expense Non Operating | $3,586,000 | $4,184,000 | $3,995,000 | $5,183,000 |
| Operating Expense | $300,085,000 | $233,713,000 | $180,219,000 | $117,809,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Net Interest Income | $8,633,000 | $6,711,000 | $3,556,000 | $-2,686,000 |
| Interest Income | $12,219,000 | $10,895,000 | $7,551,000 | $2,497,000 |
| Normalized Income | $-95,572,000 | $-91,299,000 | $-105,790,000 | $-83,613,000 |
| Net Income From Continuing And Discontinued Operation | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Total Operating Income As Reported | $-103,859,000 | $-96,614,000 | $-109,170,000 | $-80,724,000 |
| Net Income Common Stockholders | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Net Income | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Net Income Including Noncontrolling Interests | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Net Income Continuous Operations | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Pretax Income | $-95,382,000 | $-91,045,000 | $-105,817,000 | $-87,154,000 |
| Interest Income Non Operating | $12,219,000 | $10,895,000 | $7,551,000 | $2,497,000 |
| Operating Income | $-103,859,000 | $-96,614,000 | $-109,170,000 | $-80,724,000 |
| Gross Profit | $196,226,000 | $137,099,000 | $71,049,000 | $37,085,000 |
| Special Income Charges | - | $0 | $0 | $-3,258,000 |
| Per Share | ||||
| Diluted EPS | $-1.72 | $-1.75 | $-2.24 | $-1.96 |
| Basic EPS | $-1.72 | $-1.75 | $-2.24 | $-1.96 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-85,406,000 | $-81,513,000 | $-97,908,000 | $-75,589,000 |
| Reconciled Depreciation | $6,390,000 | $5,234,000 | $3,807,000 | $2,841,000 |
| EBITDA (Bullshit earnings) | $-85,406,000 | $-81,627,000 | $-98,015,000 | $-79,130,000 |
| EBIT | $-91,796,000 | $-86,861,000 | $-101,822,000 | $-81,971,000 |
| Diluted Average Shares | $55,544,000 | $52,125,000 | $47,255,000 | $44,400,000 |
| Basic Average Shares | $55,544,000 | $52,125,000 | $47,255,000 | $44,400,000 |
| Diluted NI Availto Com Stockholders | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Tax Provision | $190,000 | $368,000 | $80,000 | - |
| Research And Development | $71,277,000 | $62,298,000 | $48,446,000 | $28,981,000 |
| Selling General And Administration | $228,808,000 | $171,415,000 | $131,773,000 | $88,828,000 |
| Total Unusual Items | - | $-114,000 | $-107,000 | $-3,541,000 |
| Total Unusual Items Excluding Goodwill | - | $-114,000 | $-107,000 | $-3,541,000 |
| Gain On Sale Of Security | - | $-114,000 | $-107,000 | $-283,000 |
| Other Special Charges | - | - | - | $3,258,000 |
Fetched: 2026-07-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $365,161,000 | $401,288,000 | $279,548,000 | $195,595,000 |
| Total Assets | $508,081,000 | $534,017,000 | $404,717,000 | $309,329,000 |
| Total Non Current Assets | $57,703,000 | $52,175,000 | $54,150,000 | $36,703,000 |
| Other Non Current Assets | $9,057,000 | $5,593,000 | $3,957,000 | $3,089,000 |
| Goodwill And Other Intangible Assets | $709,000 | $932,000 | $1,204,000 | $1,477,000 |
| Other Intangible Assets | $709,000 | $932,000 | $1,204,000 | - |
| Current Assets | $450,378,000 | $481,842,000 | $350,567,000 | $272,626,000 |
| Other Current Assets | $9,648,000 | $8,453,000 | $5,213,000 | $6,175,000 |
| Inventory | $70,694,000 | $56,168,000 | $39,756,000 | $28,543,000 |
| Receivables | $83,533,000 | $83,496,000 | $48,376,000 | $15,272,000 |
| Accounts Receivable | $83,533,000 | $83,496,000 | $48,376,000 | $15,272,000 |
| Cash Cash Equivalents And Short Term Investments | $286,503,000 | $333,725,000 | $257,222,000 | $221,859,000 |
| Cash And Cash Equivalents | $286,503,000 | $333,725,000 | $257,222,000 | $221,859,000 |
| Cash Equivalents | $275,086,000 | $322,764,000 | $250,613,000 | $212,989,000 |
| Cash Financial | $11,417,000 | $10,961,000 | $6,609,000 | $8,870,000 |
| Restricted Cash | - | - | $0 | $777,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $78,483,000 | $80,250,000 | $79,204,000 | $77,317,000 |
| Long Term Debt And Capital Lease Obligation | $76,269,000 | $78,340,000 | $77,521,000 | $75,188,000 |
| Long Term Debt | $51,615,000 | $51,472,000 | $51,339,000 | $51,213,000 |
| Current Debt And Capital Lease Obligation | $2,214,000 | $1,910,000 | $1,683,000 | $2,129,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $142,211,000 | $131,797,000 | $123,965,000 | $112,257,000 |
| Total Non Current Liabilities Net Minority Interest | $76,416,000 | $78,664,000 | $78,038,000 | $76,967,000 |
| Other Non Current Liabilities | $147,000 | $324,000 | $517,000 | - |
| Current Liabilities | $65,795,000 | $53,133,000 | $45,927,000 | $35,290,000 |
| Other Current Liabilities | $7,385,000 | $6,956,000 | $5,808,000 | $3,901,000 |
| Current Deferred Liabilities | $13,048,000 | $9,565,000 | $5,656,000 | $2,855,000 |
| Payables And Accrued Expenses | $19,973,000 | $13,165,000 | $15,663,000 | $12,758,000 |
| Interest Payable | $291,000 | $310,000 | $333,000 | $532,000 |
| Payables | $18,743,000 | $12,100,000 | $15,224,000 | $10,220,000 |
| Total Tax Payable | $1,458,000 | $2,068,000 | $1,725,000 | $829,000 |
| Accounts Payable | $17,285,000 | $10,032,000 | $13,499,000 | $9,391,000 |
| Derivative Product Liabilities | - | - | $0 | $1,779,000 |
| Equity | ||||
| Common Stock Equity | $365,870,000 | $402,220,000 | $280,752,000 | $197,072,000 |
| Total Equity Gross Minority Interest | $365,870,000 | $402,220,000 | $280,752,000 | $197,072,000 |
| Stockholders Equity | $365,870,000 | $402,220,000 | $280,752,000 | $197,072,000 |
| Gains Losses Not Affecting Retained Earnings | $37,000 | $114,000 | $84,000 | $-6,000 |
| Other Equity Adjustments | $37,000 | $114,000 | $84,000 | $-6,000 |
| Retained Earnings | $-641,557,000 | $-545,985,000 | $-454,572,000 | $-348,675,000 |
| Other | ||||
| Ordinary Shares Number | $56,323,000 | $54,718,000 | $50,771,000 | $44,828,000 |
| Share Issued | $56,323,000 | $54,718,000 | $50,771,000 | $44,828,000 |
| Tangible Book Value | $365,161,000 | $401,288,000 | $279,548,000 | $195,595,000 |
| Invested Capital | $417,485,000 | $453,692,000 | $332,091,000 | $248,285,000 |
| Working Capital | $384,583,000 | $428,709,000 | $304,640,000 | $237,336,000 |
| Capital Lease Obligations | $26,868,000 | $28,778,000 | $27,865,000 | $26,104,000 |
| Total Capitalization | $417,485,000 | $453,692,000 | $332,091,000 | $248,285,000 |
| Additional Paid In Capital | $1,007,390,000 | $948,091,000 | $735,240,000 | $545,753,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $24,654,000 | $26,868,000 | $26,182,000 | $23,975,000 |
| Current Deferred Revenue | $13,048,000 | $9,565,000 | $5,656,000 | $2,855,000 |
| Current Capital Lease Obligation | $2,214,000 | $1,910,000 | $1,683,000 | $2,129,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $23,175,000 | $21,537,000 | $16,885,000 | $13,447,000 |
| Current Accrued Expenses | $1,230,000 | $1,065,000 | $439,000 | $2,538,000 |
| Net PPE | $47,937,000 | $45,650,000 | $48,989,000 | $32,137,000 |
| Accumulated Depreciation | $-12,752,000 | $-7,830,000 | $-3,669,000 | $-9,004,000 |
| Gross PPE | $60,689,000 | $53,480,000 | $52,658,000 | $41,141,000 |
| Leases | $13,225,000 | $12,488,000 | $12,362,000 | $4,941,000 |
| Construction In Progress | $4,109,000 | $262,000 | $3,548,000 | $5,671,000 |
| Other Properties | $21,513,000 | $21,047,000 | $22,369,000 | $27,269,000 |
| Machinery Furniture Equipment | $21,842,000 | $19,683,000 | $14,379,000 | $3,260,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $38,630,000 | $26,527,000 | $21,877,000 | $14,388,000 |
| Work In Process | $13,447,000 | $11,452,000 | $6,047,000 | $1,738,000 |
| Raw Materials | $18,617,000 | $18,189,000 | $11,832,000 | $12,417,000 |
| Long Term Provisions | - | - | $517,000 | - |
| Current Provisions | - | - | $232,000 | $200,000 |
| Other Inventories | - | - | - | - |
Fetched: 2026-07-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-58,341,000 | $-103,622,000 | $-133,209,000 | $-83,035,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-48,985,000 | $-99,213,000 | $-108,003,000 | $-80,382,000 |
| Cash Flow From Continuing Operating Activities | $-48,985,000 | $-99,213,000 | $-108,003,000 | $-80,382,000 |
| Operating Gains Losses | $157,000 | $114,000 | $107,000 | $3,541,000 |
| Investing Activities | ||||
| Capital Expenditure | $-9,356,000 | $-4,409,000 | $-25,206,000 | $-2,653,000 |
| Investing Cash Flow | $-9,356,000 | $-4,409,000 | $-25,206,000 | $-2,653,000 |
| Cash Flow From Continuing Investing Activities | $-9,356,000 | $-4,409,000 | $-25,206,000 | $-2,653,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $164,523,000 | $161,705,000 | $0 |
| Financing Cash Flow | $11,193,000 | $180,125,000 | $167,795,000 | $3,612,000 |
| Cash Flow From Continuing Financing Activities | $11,193,000 | $180,125,000 | $167,795,000 | $3,612,000 |
| Net Common Stock Issuance | $0 | $164,523,000 | $161,705,000 | $0 |
| Common Stock Issuance | $0 | $164,523,000 | $161,705,000 | $0 |
| Net Preferred Stock Issuance | - | - | $0 | $0 |
| Preferred Stock Issuance | - | - | $0 | $0 |
| Net Other Financing Charges | - | - | - | $-4,000,000 |
| Other | ||||
| Interest Paid Supplemental Data | $3,463,000 | $3,970,000 | $4,056,000 | $4,291,000 |
| End Cash Position | $289,541,000 | $336,763,000 | $260,260,000 | $225,674,000 |
| Beginning Cash Position | $336,763,000 | $260,260,000 | $225,674,000 | $305,097,000 |
| Effect Of Exchange Rate Changes | $-74,000 | $0 | $0 | - |
| Changes In Cash | $-47,148,000 | $76,503,000 | $34,586,000 | $-79,423,000 |
| Proceeds From Stock Option Exercised | $11,193,000 | $15,602,000 | $6,090,000 | $6,417,000 |
| Net PPE Purchase And Sale | $-9,356,000 | $-4,409,000 | $-25,206,000 | $-2,653,000 |
| Purchase Of PPE | $-9,356,000 | $-4,409,000 | $-25,206,000 | $-2,653,000 |
| Change In Working Capital | $-7,839,000 | $-47,326,000 | $-26,162,000 | $-11,487,000 |
| Change In Other Working Capital | $3,306,000 | $6,312,000 | $8,306,000 | $1,830,000 |
| Change In Other Current Liabilities | $-132,000 | $1,771,000 | $-1,149,000 | $2,986,000 |
| Change In Other Current Assets | $-2,895,000 | $-1,637,000 | $-868,000 | $-51,000 |
| Change In Payables And Accrued Expense | $8,380,000 | $2,634,000 | $9,352,000 | $11,688,000 |
| Change In Accrued Expense | $1,732,000 | $4,786,000 | $3,563,000 | $7,729,000 |
| Change In Interest Payable | $142,000 | $134,000 | $125,000 | $757,000 |
| Change In Payable | $6,648,000 | $-2,152,000 | $5,789,000 | $3,959,000 |
| Change In Account Payable | $6,648,000 | $-2,152,000 | $5,789,000 | $3,959,000 |
| Change In Prepaid Assets | $-1,102,000 | $-3,211,000 | $1,051,000 | $-1,880,000 |
| Change In Inventory | $-14,498,000 | $-17,235,000 | $-9,751,000 | $-15,251,000 |
| Change In Receivables | $-898,000 | $-35,960,000 | $-33,103,000 | $-10,809,000 |
| Changes In Account Receivables | $-898,000 | $-35,960,000 | $-33,103,000 | $-10,809,000 |
| Other Non Cash Items | $-508,000 | $-383,000 | $13,000 | $1,478,000 |
| Stock Based Compensation | $47,603,000 | $31,840,000 | $19,134,000 | $10,337,000 |
| Provisionand Write Offof Assets | $219,000 | $840,000 | $0 | $0 |
| Asset Impairment Charge | $565,000 | $1,881,000 | $995,000 | $62,000 |
| Depreciation Amortization Depletion | $6,390,000 | $5,234,000 | $3,807,000 | $2,841,000 |
| Depreciation And Amortization | $6,390,000 | $5,234,000 | $3,807,000 | $2,841,000 |
| Net Foreign Currency Exchange Gain Loss | $157,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-95,572,000 | $-91,413,000 | $-105,897,000 | $-87,154,000 |
| Repayment Of Debt | - | $0 | $0 | $-50,000,000 |
| Issuance Of Debt | - | $0 | $0 | $51,195,000 |
| Net Issuance Payments Of Debt | - | $0 | $0 | $1,195,000 |
| Net Long Term Debt Issuance | - | $0 | $0 | $1,195,000 |
| Long Term Debt Payments | - | $0 | $0 | $-50,000,000 |
| Long Term Debt Issuance | - | $0 | $0 | $51,195,000 |
| Gain Loss On Investment Securities | - | $114,000 | $107,000 | $283,000 |
Fetched: 2026-07-15